MURGF - Munich Re: Seeing A Pressured Valuation For 2026-2027E

2025-04-29 13:24:58 ET

Summary

• Munich Re has outperformed expectations, but its current valuation is significantly inflated, making it risky for new investments despite solid fundamentals and strong performance.
• The company's focus on global specialty insurance and cyber insurance is promising, but the market's premium valuation is not justified by unique operational advantages.
• Risks include potential declines in P&C volumes, market volatility, and capital intensity in the ERGO segment, which could erode earnings.
• I recommend a "Hold" rating with a PT of €400/share, as the current valuation does not offer a sufficient margin of safety for new investments.

Dear readers/followers,

To say that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München aka Munich Re ( MURGY ) has beaten my expectations would be putting it lightly. I bought the company at what has now been shown to be an extremely cheap and pressured valuation. I rotated my holdings in the company at what I then believed to be a "peak" for the company, from which the company would proceed to drop. It didn't really drop from it, however, but kept rising....

For further details see: